105 related articles for article (PubMed ID: 26075815)
1. Association of Polymorphisms in IRAK1, IRAK4 and MyD88, and Severe Invasive Pneumococcal Disease.
Carrasco-Colom J; Jordan I; Alsina L; Garcia-Garcia JJ; Cambra-Lasaosa FJ; Martín-Mateos MA; Juan M; Muñoz-Almagro C
Pediatr Infect Dis J; 2015 Sep; 34(9):1008-13. PubMed ID: 26075815
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of dysfunction of human variants of the IRAK4 kinase and a role for its kinase activity in interleukin-1 receptor signaling.
De S; Karim F; Kiessu E; Cushing L; Lin LL; Ghandil P; Hoarau C; Casanova JL; Puel A; Rao VR
J Biol Chem; 2018 Sep; 293(39):15208-15220. PubMed ID: 30115681
[TBL] [Abstract][Full Text] [Related]
3. Rare variants in MYD88, IRAK4 and IKBKG and susceptibility to invasive pneumococcal disease: a population-based case-control study.
Ellis MK; Elliott KS; Rautanen A; Crook DW; Hill AV; Chapman SJ
PLoS One; 2015; 10(4):e0123532. PubMed ID: 25886387
[TBL] [Abstract][Full Text] [Related]
4. Functional assessment of the mutational effects of human IRAK4 and MyD88 genes.
Yamamoto T; Tsutsumi N; Tochio H; Ohnishi H; Kubota K; Kato Z; Shirakawa M; Kondo N
Mol Immunol; 2014 Mar; 58(1):66-76. PubMed ID: 24316379
[TBL] [Abstract][Full Text] [Related]
5. Association of polymorphisms in the MyD88, IRAK4 and TRAF6 genes and susceptibility to type 2 diabetes mellitus and diabetic nephropathy in a southern Han Chinese population.
Guo C; Zhang L; Nie L; Zhang N; Xiao D; Ye X; Ou M; Liu Y; Zhang B; Wang M; Lin H; Yang G; Jing C
Mol Cell Endocrinol; 2016 Jul; 429():114-9. PubMed ID: 27062898
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in interleukin-1 receptor-associated kinase 4 are associated with total serum IgE.
Tewfik MA; Bossé Y; Lemire M; Hudson TJ; Vallée-Smejda S; Al-Shemari H; Laprise C; Desrosiers M
Allergy; 2009 May; 64(5):746-53. PubMed ID: 19254290
[TBL] [Abstract][Full Text] [Related]
7. IRAK4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease.
Ku CL; Picard C; Erdös M; Jeurissen A; Bustamante J; Puel A; von Bernuth H; Filipe-Santos O; Chang HH; Lawrence T; Raes M; Maródi L; Bossuyt X; Casanova JL
J Med Genet; 2007 Jan; 44(1):16-23. PubMed ID: 16950813
[TBL] [Abstract][Full Text] [Related]
8. Identification of critical residues of the MyD88 death domain involved in the recruitment of downstream kinases.
Loiarro M; Gallo G; Fantò N; De Santis R; Carminati P; Ruggiero V; Sette C
J Biol Chem; 2009 Oct; 284(41):28093-28103. PubMed ID: 19679662
[TBL] [Abstract][Full Text] [Related]
9. Paralog-specific signaling by IRAK1/4 maintains MyD88-independent functions in MDS/AML.
Bennett J; Ishikawa C; Agarwal P; Yeung J; Sampson A; Uible E; Vick E; Bolanos LC; Hueneman K; Wunderlich M; Kolt A; Choi K; Volk A; Greis KD; Rosenbaum J; Hoyt SB; Thomas CJ; Starczynowski DT
Blood; 2023 Sep; 142(11):989-1007. PubMed ID: 37172199
[TBL] [Abstract][Full Text] [Related]
10. Impaired innate immunity in mice deficient in interleukin-1 receptor-associated kinase 4 leads to defective type 1 T cell responses, B cell expansion, and enhanced susceptibility to infection with Toxoplasma gondii.
Béla SR; Dutra MS; Mui E; Montpetit A; Oliveira FS; Oliveira SC; Arantes RM; Antonelli LR; McLeod R; Gazzinelli RT
Infect Immun; 2012 Dec; 80(12):4298-308. PubMed ID: 23027530
[TBL] [Abstract][Full Text] [Related]
11. Association of an activity-enhancing variant of IRAK1 and an MECP2-IRAK1 haplotype with increased susceptibility to rheumatoid arthritis.
Han TU; Cho SK; Kim T; Joo YB; Bae SC; Kang C
Arthritis Rheum; 2013 Mar; 65(3):590-8. PubMed ID: 23233309
[TBL] [Abstract][Full Text] [Related]
12. Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk.
Sun J; Wiklund F; Hsu FC; Bälter K; Zheng SL; Johansson JE; Chang B; Liu W; Li T; Turner AR; Li L; Li G; Adami HO; Isaacs WB; Xu J; Grönberg H
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):480-5. PubMed ID: 16537705
[TBL] [Abstract][Full Text] [Related]
13. Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound.
Loiarro M; Capolunghi F; Fantò N; Gallo G; Campo S; Arseni B; Carsetti R; Carminati P; De Santis R; Ruggiero V; Sette C
J Leukoc Biol; 2007 Oct; 82(4):801-10. PubMed ID: 17548806
[TBL] [Abstract][Full Text] [Related]
14. The mechanism of activation of IRAK1 and IRAK4 by interleukin-1 and Toll-like receptor agonists.
Vollmer S; Strickson S; Zhang T; Gray N; Lee KL; Rao VR; Cohen P
Biochem J; 2017 Jun; 474(12):2027-2038. PubMed ID: 28512203
[TBL] [Abstract][Full Text] [Related]
15. MyD88 oligomer size functions as a physical threshold to trigger IL1R Myddosome signaling.
Deliz-Aguirre R; Cao F; Gerpott FHU; Auevechanichkul N; Chupanova M; Mun Y; Ziska E; Taylor MJ
J Cell Biol; 2021 Jul; 220(7):. PubMed ID: 33956941
[TBL] [Abstract][Full Text] [Related]
16. Two human MYD88 variants, S34Y and R98C, interfere with MyD88-IRAK4-myddosome assembly.
George J; Motshwene PG; Wang H; Kubarenko AV; Rautanen A; Mills TC; Hill AV; Gay NJ; Weber AN
J Biol Chem; 2011 Jan; 286(2):1341-53. PubMed ID: 20966070
[TBL] [Abstract][Full Text] [Related]
17. Association of interacting genes in the toll-like receptor signaling pathway and the antibody response to pertussis vaccination.
Kimman TG; Banus S; Reijmerink N; Reimerink J; Stelma FF; Koppelman GH; Thijs C; Postma DS; Kerkhof M
PLoS One; 2008; 3(11):e3665. PubMed ID: 18987746
[TBL] [Abstract][Full Text] [Related]
18. Clinical IRAK4 deficiency caused by homozygosity for the novel
Jia A; James E; Lu HY; Sharma M; Modi BP; Biggs CM; Hildebrand KJ; Chomyn A; Erdle S; Kular H; Turvey SE
Cold Spring Harb Mol Case Stud; 2020 Jun; 6(3):. PubMed ID: 32532880
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of human IRAK1.
Wang L; Qiao Q; Ferrao R; Shen C; Hatcher JM; Buhrlage SJ; Gray NS; Wu H
Proc Natl Acad Sci U S A; 2017 Dec; 114(51):13507-13512. PubMed ID: 29208712
[TBL] [Abstract][Full Text] [Related]
20. Single-nucleotide polymorphisms in the Toll-like receptor pathway increase susceptibility to infections in severely injured trauma patients.
Bronkhorst MW; Boyé ND; Lomax MA; Vossen RH; Bakker J; Patka P; Van Lieshout EM
J Trauma Acute Care Surg; 2013 Mar; 74(3):862-70. PubMed ID: 23425749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
